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http:WHAT THIS PAPER ADDS
This study conﬁrms that treatment of acute type B dissections should be performed by coverage of the primary
entry tear with a thoracic endograft. This technique is associated with favourable early outcomes and promotes
aortic remodelling.Objectives: This study aims to assess patient outcomes and aortic remodelling following coverage of the proximal
entry tear with an endograft in complicated acute type B aortic dissections (caTBADs).
Material and methods: All patients with caTBAD treated with a thoracic endograft in three high-volume vascular
centres were retrospectively studied. Inclusion criteria were branch-vessel malperfusion, impending or overt
aortic rupture, maximal aortic diameter 40 mm and persistent pain or uncontrolled hypertension despite
maximum pharmacological treatment. Postoperative aortic remodelling was evaluated using computed
tomography angiography (CTA) on a three-dimensional (3D) imaging workstation.
Results: A total of 52 patients (71% male, median age 65 years) were included in the study. Median inclusion
criteria per patient were 2 (range 1e4). Branch-vessel malperfusion was diagnosed in 42% and impending aortic
rupture in 33% of 52 patients. Median follow-up was 25 months (range 2e109 months). The 30-day mortality
rate was 9.6% (5/52); patient survival according to the KaplaneMeier method was 90.4% at 12 months and
87.6% at 24 months. Secondary interventions were performed in seven patients a median of 3 days after the
initial procedure (range 2e865). Imaging follow-up at 12 months was performed in 36 patients (69%): 75%
presented stable or shrinking (>5 mm) maximal aortic diameters and 86% had a completely thrombosed false
lumen (vs. 5% before initial procedure) at thoracic level.
Conclusion: Endograft treatment of complicated caTBAD is associated with favourable early outcomes and
possibly promotes aortic remodelling in the majority of patients.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Keywords: Aortic dissection, Acute, EndograftComplicated acute type B aortic dissection remains a chal-
lenging disease associated with high in-hospital mortality
rate. Open repair provides poor results.1,2 In the late 1990s,
Dake and Nienaber ﬁrst described the feasibility of the
endovascular treatment of complicated aortic dissections by
sealing the proximal entry tear with an endograft.3,4 More
than 10 years later, several series of patients with compli-
cated acute type B dissections treated with this technique
have been published with favourable5e13 clinical outcomesis work was presented at the XXVIth European Society for Vascular
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//dx.doi.org/10.1016/j.ejvs.2013.01.031and aortic remodelling often associated with false-lumen
thrombosis14,15 and true-lumen re-expansion. Few studies
include anatomical analysis of the treated, dissected aorta
during follow-up to assess the impact of endografting on
aortic remodelling.16 We have evaluated patient outcome
and aortic remodelling in a large cohort of patients treated
in three high-volume vascular centres.
MATERIAL AND METHODS
The medical records and imaging studies of all patients
treated for a complicated acute type B aortic dissection at
three high-volume vascular centres between 2004 and 2011
were reviewed. All patients included in the current study
were treated with a commercially available aortic endograft
to cover the proximal intimal entry tear (oversizing ranged
from 10% to 15%). An additional endograft was added if
a high-ﬂow secondary tear within the descending thoracic
aorta (DTA) was depicted on the angiogram after deploy-
ment of the ﬁrst endograft. In our study, a dissection was
Table 1. Patient characteristics.
Number of patients 52
Men (n, %) 37 (71%)
Age (median, range) 65 (21e82)
Known hypertension (n, %) 48 (92%)
COPD (n, %) 16 (31%)
ASA classiﬁcation (n, %)
ASA 1 6 (11%)
ASA 2 13 (25%)
ASA 3 24 (46%)
ASA 4 9 (18%)
ASA: American Society of Anesthesiologists; COPD: chronic
obstructive pulmonary disease.
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symptoms and the treatment was <14 days. Inclusion
criteria to consider the dissection as complicated were
branch-vessel malperfusion, impending or overt aortic
rupture or peri-aortic effusion, maximal transaortic diam-
eter over 40 mm and persistent pain or uncontrolled
hypertension despite maximum pharmacological treatment.
Impending or overt aortic rupture or periaortic effusion was
the presence of periaortic suffusion with or without
evidence of contrast extravasation on the preoperative
computed tomography angiography (CTA) scan.
Demographic data including age and sex and co-
morbidities were collected. Surgical data including number
of endografts implanted, early additional procedures,
median length of stay and 30-day mortality rate were
collected. All major events (including complications after
endovascular aneurysm repair (EVAR) as described by
Chaikof et al.)17 and secondary interventions during the
follow-up period were also recorded.
All patients included had a CTA scan before endovas-
cular repair. CTAs were considered workable if they
included high-quality arterial and venous contrast-
enhanced phases and a maximum slice thickness of 3 mm.
All CTAs were analysed on a dedicated three-dimensional
(3D) imaging workstation by two vascular surgeons with
a large experience in endograft planning (J.S and S.H).
Diameter measurements were assessed according to the
centreline of ﬂow (CLF) using a semi-automated centreline
algorithm as previously described.18 The centreline was
controlled (and corrected if needed) manually by scrolling
through the multiplanar reconstruction (MPR) images. The
exact level of the proximal entry tear location on the
preoperative CTA was collected (above the left subclavian
(LSCA), aorta at LSCA, LSCA and DTA). The high-ﬂow
secondary entry tear was also searched along the
dissected aorta; it was described as an obvious contrast-
enhanced intimal tear of the intimal ﬂap distal to the
major proximal entry tear causing the entry of blood into
the false lumen.
Aortic remodelling was evaluated by analysis of the ﬂow
status of the false lumen in the DTA and in the abdominal
aorta; and by evaluation of the aortic diameters at thoracic
and abdominal levels during the follow-up period (maximal
transaortic diameters on the CPR were considered). The
aortic diameter was considered stable when the diameter
variation was strictly inferior to 5 mm (5 mm; þ5 mm).
The false-lumen status was deﬁned at thoracic (the entire
DTA from the LSCA to the diaphragm) and abdominal (from
diaphragm to aorto-iliac bifurcation) levels as patent,
partially thrombosed or totally thrombosed; partial throm-
bosis is deﬁned as the concurrent presence of both contrast
enhancement corresponding to ﬂow and thrombus within
the lumen.
Statistical analysis
All data were analysed using the Statistical Package for the
Social Sciences (SPSS) software version 17.0 (SPSS Inc.,
Chicago, IL, USA).Continuous variables are expressed as median with range
or mean  standard deviation (SD) and categorical data as
percentage.
Comparisons between groups were made with t-tests or
ManneWhitney tests for continuous variables and with the
chi-squared test for categorical variables.
A life table according to the KaplaneMeier method was
conducted to estimate survival and freedom-from-
secondary-intervention rates and differences were tested
with the log-rank test.
A p-value of <0.05 was considered as statistically
signiﬁcant.
RESULTS
Between 2004 and 2011, the medical records and imaging
studies of 52 consecutive patients (71% male, median age
65 years) with complicated acute type B aortic dissection
were identiﬁed and included in our study. Demographics are
summarised in Table 1.
All 52 patients were treated within 14 days after the onset
of the symptoms (median 3 days, range 0e13). Median
number of inclusion criteria per patient was 2 (range 1e4)
(Table 2). Branch-vessel malperfusion was diagnosed in 42%
and effusion peri-aortic and/or impending aortic rupture in
33% of 52 patients. Initial surgical intervention included
endograft implantation for all patients (Gore TAG endo-
prosthesis,W.L. Gore & Associates, Flagstaff, AZ, USA; and/or
COOK Zenith TX2, Cook Medical, Bloomington, IN, USA; and/
or Medtronic Talent Thoracic Stent Graft System, Medtronic
Cardiovascular, Santa Rosa, CA, USA); the number of
endografts deployed and all additional procedures are re-
ported in Table 3; left subclavian artery (LSCA) coverage was
required to exclude the proximal entry tear of the dissected
aorta in 29 (56%) patients. LSCA revascularisation was per-
formed in four patients (8%). A completion angiogram at the
end of the initial procedure conﬁrmed the absence of
persistent malperfusion of visceral, renal and iliac arteries. If
a high-ﬂow secondary entry tear in the DTA was depicted, an
additional endograft was implanted. If persistent malperfu-
sion was observed after endograft deployment, additional
visceral, renal or iliac stenting was performed.
The 30-day mortality rate and the in-hospital mortality
rate were 9.6% each (5/52); patient survival according to
the KaplaneMeier method was 90.4% at 12 months and
Figure 1. KaplaneMeier estimates for cumulative survival (red line)
and freedom-from-secondary intervention (dotted blue line).
Table 4. Postoperative deaths.
Time between
initial procedure
and death (days)
Cause of death Inclusion criteria
3 Rupture Impending rupture
6 Multiple organ Impending rupture &
Table 2. Inclusion criteria.
Number of patients, % 52 (100%)
Effusion/hematoma periaortic and/or impending
rupture
17 (33%)
Branch vessel malperfusion 22 (42%)
Coeliac trunk and superior mesenteric artery 11 (22%)
Renal artery(ies) 9 (18%)
Iliac artery(ies) 8 (16%)
Spinal cord ischaemia 2 (4%)
Maximal transaortic diameter 40 mm 24 (46%)
Persistent pain 24 (46%)
Uncontrolled hypertension 11 (21%)
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rate according to the KaplaneMeier method was 76% and
68% at 12 and 24 months respectively, when the patient
presented an impending rupture or peri-aortic effusion
at initial presentation and 97% at 12 and 24 months
when the patient did not (log-rank test: chi2 ¼ 6.055;
p-value ¼ 0.014).
Postoperative deaths are detailed in Table 4. Only
patients with multiple organ failure needed temporary
dialysis; no patient required long-term dialysis in our cohort.
Major postoperative complications are listed in Table 5.
Median length of hospital stay was 12 days (range 7e39).
Median follow-up was 25 months (range 2e109 months).
Secondary interventions were performed in seven
patients a median of 3 days (range 2e865) after the initial
procedure. The freedom-from-secondary-intervention rate
according to the KaplaneMeier method was 87.5% at 12
months and 24 months (cf. Fig. 1). Secondary interventions
are listed in Table 6.
Imaging follow-up at 12 months was performed in 36
(69%) patients (41 patients had a follow-up of 12 months or
more, but 5 patients had their 12-month CTA performed in
a community hospital and were not available for analysis). A
stable or shrinking (>5 mm) maximal aortic diameter of the
thoracic aorta was observed in 75% of patients at 12
months (enlargement: 25%; stable: 53%; and shrinkage:
22%) and in 67% at abdominal level. Total thrombosed false
lumen at thoracic level was observed in 86% of patients
(compared to 5% before endograft implantation) (Table 7).
The chi-squared analysis conducted to correlate death
and secondary interventions with any risk factors isTable 3. Initial procedure.
Number of patients 52
Number of endoprosthesis implanted (median,
[range])
1 [1e2]
Left subclavian artery coverage 29 (56%)
Additional procedure at initial time:
LSCA revascularization 4 (8%)
Fenestration 2 (4%)
Renal stenting 6 (12%)
CT and/or SMA stenting 0
Iliac stenting 7 (13%)
Length of stay in days (median, range) 12 [7e39]
LSCA: left subclavian artery; CT: coeliac trunk; SMA: superior
mesenteric artery.reported in Tables 8(a) and 8(b). Five criteria were statis-
tically associated with mortality: the existence at initial
presentation of a primary intimal entry tear located in the
DTA (p ¼ 0.028), limb ischaemia (p ¼ 0.014), effusion
haematoma and/or impending rupture (p ¼ 0.019), longer
interval (from 0 to 14 days) between the onset of symptoms
and treatment and the existence at 12 months of a high-
ﬂow secondary entry tear (p < 0.001). No risk factor for
secondary intervention was depicted.
DISCUSSION
Our study conﬁrmed that endograft implantation to cover
the proximal entry tear in complicated acute type B aortic
dissection is associated with favourable early and midterm
outcomes.
Survival
Most series with similar complicated patients also treated
by endograft implantation report a 30-day mortality rate in
the region of 10%.9e12 In our study, the 30-day mortalityfailure branch malperfusion
6 Multiple organ
failure
Impending rupture
17 Mesenteric
infarction
Branch malperfusion
23 Multiple organ
failure
Impending &
malperfusion diameter &
transaortic diameter
40 mm
479 Rupture Impending rupture
748 Myocardial
infarction
Impending rupture
1095 Rupture Branch malperfusion
2027 Unknown Transaortic diameter
40 mm
Table 6. Secondary intervention.
Interval between
initial procedure
and secondary
intervention (in days)
Diagnosed
complication
Procedure
2 Paraplegia Carotid-LSCA
bypass
2 Stroke Carotid-LSCA
bypass
2 Left renal artery
malperfusion
Left renal artery
stenting
3 Rupture below
the ﬁrst
stentgraft
Distal thoracic
endograft extension
5 Paraplegia Carotid-LSCA
bypass
45 Left renal artery
malperfusion
Left renal artery
stenting
865 Secondary entry
tear
Distal thoracic
endograft extension
J. Sobocinski et al. 471rate was 9.6% and the 1-year survival rate was 90%, despite
critical presentation at initial admission (42% of patients
with branch malperfusion and 33% with effusion haema-
toma and/or impending rupture). Those results are consis-
tent with the current literature. During the follow-up
period, death was ‘aortic dissection related’ in more than
half of the patients (cf. Table 4).
The persistence of a high-ﬂow secondary entry tear on
the postoperative CTA had a signiﬁcant (p < 0.001) inﬂu-
ence on the survival rate. This is consistent with the liter-
ature; these high-ﬂow secondary re-entry tears maintain
false-lumen ﬂow and are associated with a high mortality
rate during follow-up.14,19
Branch malperfusion
Of the 22 (42%) patients treated for branch malperfusion at
initial time, 17 (33%) required one or multiple additional
revascularisations (Table 3). During follow-up six more
patients required a secondary intervention because of
persistent branch malperfusion (renal or spinal cord
ischaemia (SCI)). In the STABLE trial, 13 (48%) branch
selective stenting procedures were performed at initial
procedure on 27 patients with branch malperfusion and
one additional renal stenting 18 days after the initial
procedure.20 The bare aortic stents possibly enhance the
perfusion of the true lumen and thus increase branch-vessel
perfusion.
Spinal cord ischaemia
SCI was demonstrated after endograft implantation in ﬁve
patients (9.6%), representing half of all major complications
(10 patients, 19%). No recovery was observed in two
patients despite performing left-subclavian revascularisa-
tion and cerebrospinal ﬂuid (CSF) drainage after SCI had
been depicted (respectively on the second and the ﬁfth
postoperative day). A minimum of two endografts (aortic
coverage  200 mm) were implanted in all ﬁve patients;
only one had no LSCA coverage, but none had left-subcla-
vian revascularisation performed at the time of the
endograft implantation. We thus recommend implanting
a single, short endograft (<15 cm) whenever possible andTable 5. Major postoperative complications.
Delay between initial
treatment and complication
occurrence (days)
Organ
affected
Type of
complication
3 Pulmonary Pneumonia
3 Vascular Aortic rupture
2 Vascular Left renal
malperfusion
44 Vascular Left renal
malperfusion
Postoperative Neurologic Paraparesis
Postoperative Neurologic Paraparesis
Postoperative Neurologic Paraparesis
Postoperative Neurologic Stroke
Postoperative Neurologic Paraplegia
5 Neurologic Paraplegiaperforming a left-subclavian revascularisation when exten-
sive aortic coverage (>20 cm) is required.
The aortic coverage length and the LSCA coverage with or
without previous revascularisation have been described as
SCI21 risk factors. When coverage is required in elective
patients, routine LSCA revascularisation has been sug-
gested.22 In acute aortic syndrome repair, the guidelines are
less clear and the decision to revascularise at the same time
and the use of other prophylactic manoeuvres such as CSF
drainage is discussed according to the patient’s condition,
the degree of emergency and the planned length of aortic
coverage.Aortic remodelling
Aortic remodelling during follow-up was favourable in our
study although thoracic endografting was limited to prox-
imal intimal entry tear coverage whenever possible.
As previously stated, a new endovascular dissection
device with bare-metal dissection stents distal to a regular
endograft is currently being evaluated;20 the thor-
acoabdominal aortic scaffolding with the bare-metal stents
is intended to promote aortic remodelling and true-lumen
expansion. In the STABLE trial, only 31.3% of patients hadTable 7. False lumen status in the thoracic and in the abdominal
aorta at initial presentation and 12 months after (36 patients
had complete imaging follow-up at 12 months).
Thoracic level Abdominal level
Initial
time
At 12
months
Initial
time
At 12
months
Partially
thrombosed
15 (42%) 5 (14%) 6 (16.7%) 7 (18.4%)
Completely
thrombosed
2 (5%) 31 (86%) 1 (2.7%) 12 (33.3%)
Patent 19 (53%) 0 18 (50%) 6 (16.7%)
Not applicable 0 0 11 (30.6%) 11 (30.6%)
Table 8a. Chi-square correlation between death and any variable of interest.
Variables Khi-2 p-value
Sex 0.836 0.361
Delay between the onset of symptom and
endovascular treatment (t-student test)
2.870 0.013
Effusion peri-aortic and/or impending rupture 5.516 0.019
Resistant hypertension 2.284 0.131
Persistent pain 0.035 0.851
Aortic diameter rapid growth up to 5 mm within
3 months
0.159 0.690
Maximal aortic diameter up to 40 mm 0.035 0.851
Aortic branch malperfusion 0.729 0.393
Organ involved: GastroIntestinal 0.556 0.456
Organ involved: Kidney 0.004 0.947
Organ involved: Spine 0.278 0.598
Organ involved: Limb 6.054 0.014
Preoperative characteristics Primary entry tear location (above left
SubClavian, aorta at LSCA, LSCA, descending
thoracic aorta)
9.748 0.008
Entry tear in descending thoracic aorta 4.843 0.028
Secondary entry tear 3.561 0.938
Proximal aspect of dissection (below left carotid,
below left subclavian artery)
5.206 0.157
Preoperative thoracic false lumen status (patent,
partially thrombosed or totally thrombosed)
6.733 0.081
Preoperative abdominal false lumen status
(patent, partially thrombosed or totally
thrombosed)
4.301 0.231
Initial procedure Number of endoprosthesis implanted 1.477 0.224
Carotido SubClavian bypass 0.882 0.348
Iliac stenting 1.585 0.208
Renal stenting 0.060 0.807
Aortic branch selective stenting 0.717 0.397
1 year follow-up imaging Thoracic proximal type 1 endoleak 0.05 0.823
Thoracic distal type 1 endoleak 0.05 0.823
Abdominal type 1 0.051 0.821
Secondary entry tear 20.451 <0.001
Thoracic aortic diameter variation 0.77 0.781
Abdominal aortic diameter variation 0.465 0.496
Follow-up Secondary intervention 1.258 0.262
Hospital stay length (t-student test) 0.537 0.626
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months. Furthermore, at the abdominal level the false
lumen was partially or completely thrombosed in 81.3%
and 3.1% of the patients, respectively.20 In our study,
where no bare-metal stents were implanted in the aorta
distal to the endograft covering the proximal entry tear,
86% of the patients had a complete thrombosed false
lumen at the thoracic aorta at 12 months, which compares
favourably with the STABLE trial. Similar ﬁgures have been
reported in other series with up to 90% of false-lumen
thrombosis at 12 months.15 Moreover, in our study the
median value of maximal transaortic thoracic diameter was
stable over time (40.0 at initial time vs. 38.5 mm at 12
months; p ¼ 0.914). There was a minor but statisticallysigniﬁcant increase of the abdominal aortic diameter (25.5
at initial time vs. 28.0 mm at 12 months; p ¼ 0.001), whilst
in the STABLE trial there was no signiﬁcant aortic diameter
changes (true lumen) at this location. The thoracic and
abdominal diameters were unchanged or shrinking
(>5 mm) at 12 months, respectively, in 75% and 67% of
the patients.
There are some limitations to our study:
 The deﬁnition of complicated dissection is not clearly
established in the literature. It has been largely
reported that patients with acute dissections presenting
an initial aortic diameter of 40 mm and over are
considered at high risk to develop aortic-related
Table 8b. Chi-square correlation between secondary intervention and any variable of interest.
Khi-2 p-value
Sex 0.774 0.379
Delay between the onset of symptom and
endovascular treatment (t-student test)
0.300 0.765
Effusion peri-aortic and/or impending rupture 0.062 0.803
Resistant hypertension 2.170 0.141
Persistent pain 0.035 0.851
Largest thoracic diameter (t-student test) 0.158 0.539
Maximal aortic diameter up to 40 mm 1.006 0.316
Aortic branch malperfusion 0.001 0.975
Organ involved: GastroIntestinal 0.254 0.614
Organ involved: Kidney 1.739 0.187
Organ involved: Spine 2.313 0.128
Organ involved: Limb 1.019 0.313
Preoperative characteristics Primary entry tear location (above left
SubClavian, aorta at LSCA, LSCA, descending
thoracic aorta)
0.201 0.904
Secondary entry tear 9.897 0.359
Proximal aspect of dissection (below left carotid,
below left subclavian artery)
3.026 0.388
Preoperative thoracic false lumen status (patent,
partially thrombosed or totally thrombosed)
3.515 0.319
Preoperative abdominal false lumen status
(patent, partially thrombosed or totally
thrombosed)
2.553 0.466
Initial procedure Number of endoprosthesis implanted 0.131 0.718
Left subclavian coverage 2.940 0.086
Carotido SubClavian bypass 2.135 0.144
Iliac stenting 0.005 0.945
Renal stenting 0.060 0.807
Aortic branch selective stenting 0.052 0.820
1 year follow-up imaging Thoracic proximal type 1 endoleak 0.135 0.714
Thoracic distal type 1 endoleak 0.135 0.714
Secondary entry tear 0.767 0.381
Thoracic aortic diameter Variation 0.697 0.404
Abdominal aortic diameter variation 2.903 0.088
Follow-up Hospital stay length (t-student test) 0.243 0.810
J. Sobocinski et al. 473morbidity and mortality.23e25 We thus decided to
include this criterion in our deﬁnition of complicated
acute type B dissections. In our current acute cohort,
only ﬁve patients (5/52 ¼ 9.6%) have been included
based on this single criterion.
 Only aortic diameters have been assessed to evaluate
aortic-size variations. Nonetheless, diameters have
proved to be reliable when compared with aortic-volume
analysis in assessing aortic remodelling during follow-
up.26 No standardised clinical protocol was used and the
data summarise the local protocols in the three centres
participating in this study. These were nevertheless very
similar.
 The reliability of the false-lumen-patency analysis by CTA
(including a true late venous phase) can be questioned. A
magnetic resonance imaging (MRI) analysis would
probably be more accurate but most endograftsimplanted have a stainless-steel metallic frame that
contraindicates this examination.CONCLUSION
Endograft coverage of the primary entry tear in complicated
acute type B aortic dissection is associated with good early
outcomes and possibly promotes aortic remodelling in
a large majority of patients.
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